Atlas Trials

A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation

Clinical trial NCT07759154 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07759154
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Attention-deficit/Hyperactivity DisorderEmotional Dysregulation
Start date
2026-08-20
Primary completion
2027-05-27
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.